Analystreport

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) had its price target raised by analysts at BofA Securities from $25.00 to $40.00. They now have a "buy" rating on the stock.

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report